Select Equity Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.04M Hold
3,300
0.02% 155
2025
Q4
$3.55M Sell
3,300
-400
-11% -$382K 0.02% 172
2025
Q3
$2.82M Sell
3,700
-13,700
-79% -$10.2M 0.01% 158
2025
Q2
$13.6M Buy
17,400
+9,300
+115% +$7.23M 0.06% 105
2025
Q1
$6.69M Buy
8,100
+100
+1% +$83.2K 0.03% 126
2024
Q4
$6.18M Hold
8,000
0.02% 105
2024
Q3
$7.09M Buy
8,000
+200
+3% +$180K 0.03% 101
2024
Q2
$7.06M Sell
7,800
-1,700
-18% -$1.36M 0.03% 114
2024
Q1
$7.39M Buy
+9,500
New +$6.76M 0.03% 111

Other funds holding LLY

Select Equity Group's LLY Position: Q1 2026 in Review

Select Equity Group opened a new position in Eli Lilly (LLY) in Q1 2026: 14 shares worth $12.9K. The stake represents ﹤0.01% of the portfolio and ranks #175 among its holdings.

4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Select Equity Group held 14 shares of Eli Lilly worth $12.9K as of Q1 2026.
  • Eli Lilly was a new Select Equity Group position in Q1 2026.
  • Eli Lilly made up ﹤0.01% of Select Equity Group's portfolio in Q1 2026, its #175 holding.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Select Equity Group's 13F filing for Q1 2026, filed 15 May 2026.